N. participants (total)
|
34,513
|
12,781
|
3109
|
3513
| |
SBP, mmHg
|
135.9 ± 21.4
|
134.8 ± 20.8
|
132.6 ± 20.2
|
132.6 ± 20.7
| |
Unadjusted β (95% CI)
|
Ref
|
− 1.14 (− 1.57, − 0.71)
|
− 3.39 (− 4.16, − 2.61)
|
− 3.36 (− 4.09, − 2.62)
|
< 0.0001
|
Model 1 adjusted β (95% CI)
|
Ref
|
0.73 (0.32, 1.14)
|
− 0.20 (− 0.94, 0.55)
|
− 0.30 (− 1.00, 0.41)
|
0.88
|
Model 2 adjusted β (95% CI)
|
Ref
|
0.74 (0.32, 1.15)
|
− 0.06 (− 0.81, 0.69)
|
− 0.21 (− 0.92, 0.49)
|
0.63
|
Model 3 adjusted β (95% CI)
|
Ref
|
0.31 (− 0.08, 0.71)
|
− 0.41 (− 1.13, 0.31)
|
− 0.96 (− 1.64, − 0.27)
|
0.03
|
N. participants (males)a
|
13,211
|
5900
|
1581
|
1881
| |
SBP, mmHg
|
137.0 ± 20.8
|
136.3 ± 19.9
|
134.8 ± 19.7
|
135.5 ± 20.4
| |
Unadjusted β (95% CI)
|
Ref
|
− 0.74 (− 1.37, − 0.11)
|
− 2.24 (− 3.31, − 1.17)
|
− 1.55 (− 2.54, − 0.56)
|
< 0.0001
|
Model 1 adjusted β (95% CI)
|
Ref
|
1.02 (0.40, 1.63)
|
0.52 (− 0.52, 1.56)
|
0.84 (− 0.12, 1.80)
|
0.01
|
Model 2 adjusted β (95% CI)
|
Ref
|
0.94 (0.32, 1.55)
|
0.61 (− 0.43, 1.65)
|
0.87 (− 0.09, 1.84)
|
0.01
|
Model 3 adjusted β (95% CI)
|
Ref
|
0.19 (− 0.40, 0.79)
|
− 0.43 (− 1.44, 0.57)
|
− 0.60 (− 1.54, 0.34)
|
0.24
|
N. participants (females)a
|
21,302
|
6881
|
1528
|
1632
| |
SBP, mmHg
|
135.3 ± 21.8
|
133.5 ± 21.5
|
130.3 ± 20.4
|
129.3 ± 20.6
| |
Unadjusted β (95% CI)
|
Ref
|
− 1.74 (− 2.33, − 1.15)
|
− 5.01 (− 6.13, − 3.89)
|
− 6.01 (− 7.09, − 4.92)
|
< 0.0001
|
Model 1 adjusted β (95% CI)
|
Ref
|
0.52 (− 0.04, 1.08)
|
− 0.92 (− 1.98, 0.14)
|
− 1.44 (− 2.47, − 0.41)
|
0.03
|
Model 2 adjusted β (95% CI)
|
Ref
|
0.59 (0.04, 1.15)
|
− 0.69 (− 1.75, 0.37)
|
− 1.23 (− 2.27, − 0.20)
|
0.12
|
Model 3 adjusted β (95% CI)
|
Ref
|
0.46 (− 0.08, 0.99)
|
− 0.37 (− 1.39, 0.64)
|
− 1.06 (− 2.06, − 0.07)
|
0.03
|